Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 24, Issue 7, Pages 624-632
Publisher
Wiley
Online
2018-04-15
DOI
10.1111/cns.12852
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurovascular Unit Dysfunction and Blood–Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence
- (2017) Souhel Najjar et al. Frontiers in Psychiatry
- Nitric oxide attenuates overexpression of Giα proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling
- (2017) Oli Sarkar et al. PLoS One
- Prediction of conversion to psychosis: review and future directions
- (2017) Dylan G. Gee et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
- (2016) J. M. Stone et al. PSYCHOLOGICAL MEDICINE
- Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model
- (2016) Camila Mauricio Santos et al. SCHIZOPHRENIA RESEARCH
- Declining transition rates to psychotic disorder in “ultra-high risk” clients: Investigation of a dilution effect
- (2016) Jessica A. Hartmann et al. SCHIZOPHRENIA RESEARCH
- Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
- (2016) Fernanda F. Peres et al. Frontiers in Pharmacology
- Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
- (2015) Ludmyla Kandratavicius et al. BMC NEUROSCIENCE
- Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis
- (2015) Jose Crippa et al. CNS & Neurological Disorders-Drug Targets
- The role of nitric oxide donors in schizophrenia: Basic studies and clinical applications
- (2015) Nikolaos Pitsikas EUROPEAN JOURNAL OF PHARMACOLOGY
- The Effects of Sodium Nitroprusside Treatment on Cognitive Deficits in Schizophrenia
- (2015) Joao Paulo Maia-de-Oliveira et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Low expression of Gria1 and Grin1 glutamate receptors in the nucleus accumbens of Spontaneously Hypertensive Rats (SHR)
- (2015) Mariana C. Diana et al. PSYCHIATRY RESEARCH
- The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats
- (2015) Aikaterini Trevlopoulou et al. PSYCHOPHARMACOLOGY
- Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week
- (2015) Joao Paulo Maia-de-Oliveira et al. SCHIZOPHRENIA RESEARCH
- Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects
- (2015) Regina F. Nasyrova et al. Frontiers in Physiology
- Expression profile of neurotransmitter receptor and regulatory genes in the prefrontal cortex of spontaneously hypertensive rats: Relevance to neuropsychiatric disorders
- (2014) Marcos Leite Santoro et al. PSYCHIATRY RESEARCH
- Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems
- (2014) Joao Paulo Maia-de-Oliveira et al. SCHIZOPHRENIA RESEARCH
- Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
- (2014) Valéria Almeida et al. SCHIZOPHRENIA RESEARCH
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- Impact of neonatal NOS-1 inhibitor exposure on neurobehavioural measures and prefrontal-temporolimbic integration in the rat nucleus accumbens
- (2013) Alexander M. Dec et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice
- (2013) Ana C. Issy et al. PSYCHOPHARMACOLOGY
- Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside
- (2013) Jaime E. C. Hallak et al. JAMA Psychiatry
- Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
- (2012) Hans-Gert Bernstein et al. CNS & Neurological Disorders-Drug Targets
- Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
- (2012) Raquel Levin et al. CURRENT PHARMACEUTICAL DESIGN
- Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice
- (2012) Kiersten S. Smith et al. NEUROPHARMACOLOGY
- Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
- (2012) Valéria Almeida et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats
- (2011) Mariana Bendlin Calzavara et al. BEHAVIOURAL BRAIN RESEARCH
- The contextual fear conditioning deficit presented by spontaneously hypertensive rats (SHR) is not improved by mood stabilizers
- (2011) Mariana Bendlin Calzavara et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine
- (2011) Raquel Levin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia
- (2011) João Paulo Maia de Oliveira et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective
- (2010) Deborah Nicholl et al. CURRENT MEDICAL RESEARCH AND OPINION
- Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders
- (2010) Molly K Larson et al. Expert Review of Neurotherapeutics
- Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study
- (2010) Yuichiro Nakano et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling
- (2009) A. Masood et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Neonatal administration of N-omega-nitro-l-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by d-amphetamine in postpubertal rats
- (2008) Julio César Morales-Medina et al. NEUROPHARMACOLOGY
- Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat
- (2008) Mark D. Black et al. PSYCHOPHARMACOLOGY
- Neuroleptic Drugs Revert the Contextual Fear Conditioning Deficit Presented by Spontaneously Hypertensive Rats: A Potential Animal Model of Emotional Context Processing in Schizophrenia?
- (2008) M. B. Calzavara et al. SCHIZOPHRENIA BULLETIN
- Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls
- (2008) Bun-Hee Lee et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation